HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

Antifungal Agents

Antifungal Agents

In the realm of antimicrobials, antifungal agents stand as a specialized arsenal against fungal pathogens. Among the diverse classes of antifungal drugs, allylamines such as terbinafine disrupt fungal cell membrane synthesis by inhibiting squalene epoxidase. This class is particularly effective against dermatophyte infections like ringworm. Flucytosine, an antimetabolite, interferes with nucleic acid synthesis in fungi. It is often used in combination with other antifungal drugs for systemic mycoses. Griseofulvin, another unique agent, disrupts fungal cell division by targeting microtubules, making it effective against dermatophyte infections of the skin, hair, and nails. As with any antimicrobial, antifungal agents require careful consideration of their side effects, drug interactions, and the specific fungal species causing the infection. The continuous development of novel antifungal agents remains imperative to stay ahead in the ongoing battle against fungal infections.

Committee Members
Speaker at World Congress on Infectious Disease 2025 - Reza Nassiri

Reza Nassiri

Michigan State University, United States
Speaker at World Congress on Infectious Disease 2025 - Francis J Castellino

Francis J Castellino

University of Notre Dame, United States
Speaker at World Congress on Infectious Disease 2025 - Saurabh Chattopadhyay

Saurabh Chattopadhyay

University of Kentucky College of Medicine, United States
WCID 2025 Speakers
Speaker at World Congress on Infectious Disease 2025 - Johnson J H Wang

Johnson J H Wang

Wang Electro-Opto Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Victor J Alexander

Victor J Alexander

Capital Stem Cell Research Corporation, United States
Speaker at World Congress on Infectious Disease 2025 - Jacob R Miller

Jacob R Miller

Penn State University, United States
Speaker at World Congress on Infectious Disease 2025 - Anmol Grewal

Anmol Grewal

Abrazo Health, United States

Submit your abstract Today

Newsletter

By signing up, you agree to join our mailing list to receive information and updates.

Watsapp